Status:
UNKNOWN
NT-proBNP and Troponin I in Dengue Children
Lead Sponsor:
Le Phuoc Truyen
Conditions:
Dengue Shock Syndrome
Children, Only
Eligibility:
All Genders
1-18 years
Brief Summary
To discribe concentration of NT-proBNP and Troponin I in Dengue hemorrhagic shock children, in correlation between concentration of NT-proBNP and troponin I with total fluid admission, respiratory sup...
Detailed Description
Treatment of children with Dengue hemorrhagic shock syndrome (DSS) is challenge, especially in cases with hypotensive shock, profound shock or whom do not have a response to initial crystalloid therap...
Eligibility Criteria
Inclusion
- Dengue shock children who admitted to ICU
Exclusion
- Excluding the cases of children with cardiovascular disease, hyperthyroidism, taking drugs such as insulin, steroid, estrogen, growth hormone, thyroid hormone
Key Trial Info
Start Date :
April 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04837430
Start Date
April 2 2021
End Date
December 31 2023
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of medicine and pharmacy at Ho Chi Minh city
Ho Chi Minh City, Vietnam, 700000